4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-22-056644
Director sold 53,926 shares at an average $17.05 ($919,589)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SCHIFF ANDREW N Director | 2022-11-10 | Sale | −11,395 | $17.02 | $193,995 | 476,986 | I: show line 1 in the form |
| SCHIFF ANDREW N Director | 2022-11-11 | Sale | −41,160 | $17.06 | $702,177 | 435,826 | I: show line 2 in the form |
| SCHIFF ANDREW N Director | 2022-11-14 | Sale | −1,371 | $17.08 | $23,417 | 434,455 | I: show line 3 in the form |
| Open-market sales · 53,926 sh · avg $17.05 · $919,589 | |||||||
Loading xslF345X03/doc4.xml…